[Form 4] Dolby Laboratories, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Dolby Laboratories director and SVP of Advanced Technology Group, Shriram Revankar, reported an insider sale of 7,000 shares of Class A common stock on 08/22/2025 at a reported price of $74.92 per share. After the sale, Revankar beneficially owned 70,435 shares. The filing discloses that 47,766 of those shares are Class A shares underlying restricted stock units that remain subject to forfeiture until they vest. The Form 4 was signed by an attorney-in-fact on 08/26/2025.

Insights

Financial Analyst

TL;DR Insider sold a modest block of shares; holding remains substantial with significant unvested RSUs.

The sale of 7,000 shares at $74.92 represents a standard Section 16 disclosure of personal trading by a senior executive. The seller still beneficially owns 70,435 shares, including 47,766 shares tied to restricted stock units that are not yet vested and remain subject to forfeiture. This transaction does not, on its face, indicate a material change to control or ownership percentage; it is routine insider liquidity rather than an unusual divestiture. No additional compensation, hedging, or derivative activity was reported in this filing.

Corporate Governance Expert

TL;DR Routine insider sale disclosed properly; vesting schedule may influence alignment with shareholders.

The Form 4 shows compliance with Section 16 reporting requirements through timely disclosure. The large portion of shares represented by unvested restricted stock units suggests continued retention incentives and alignment with long-term performance objectives. Because the filing shows a single non-derivative sale and a substantial remaining stake, the governance implication is limited and appears consistent with normal executive compensation and liquidity management practices.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Revankar Shriram

(Last) (First) (Middle)

C/O DOLBY LABORATORIES, INC.

1275 MARKET STREET

(Street)

SAN FRANCISCO CA 94103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Advanced Technology Group

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/22/2025		S		7,000	D	$74.92	70,435(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares held following the reported transactions include 47,766 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

	/s/ Daniel Rodriguez as Attorney-in-Fact for Shriram Revankar	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.